Interfacing Sca‐1pos Mesenchymal Stem Cells with Biocompatible Scaffolds with Different Chemical Composition and Geometry
Open Access
- 1 January 2009
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2009 (1) , 910610
Abstract
An immortalized murine mesenchymal stem cell line (mTERT‐MSC) enriched for Linneg/Sca‐1pos fraction has been obtained through the transfection of MSC with murine TERT and single‐cell isolation. Such cell line maintained the typical MSC self‐renewal capacity and continuously expressed MSC phenotype. Moreover, mTERT‐MSC retained the functional features of freshly isolated MSC in culture without evidence of senescence or spontaneous differentiation events. Thus, mTERT‐MSC have been cultured onto PLA films, 30 and 100 μm PLA microbeads, and onto unpressed and pressed HYAFF‐11 scaffolds. While the cells adhered preserving their morphology on PLA films, clusters of mTERT‐MSC were detected on PLA beads and unpressed fibrous scaffolds. Finally, mTERT‐MSC were not able to colonize the inner layers of pressed HYAFF‐11. Nevertheless, such cell line displayed the ability to preserve Sca‐1 expression and to retain multilineage potential when appropriately stimulated on all the scaffolds tested.Keywords
Funding Information
- Italian Institute for Cardiovascular Research (N40G.25)
- Istituto Superiore di Sanità (N40G.25)
This publication has 30 references indexed in Scilit:
- Faculty Opinions recommendation of Fibroblast precursors in normal and irradiated mouse hematopoietic organs.2011
- A novel hyaluronan-based biomaterial (Hyaff-11®) as a scaffold for endothelial cells in tissue engineered vascular graftsBiomaterials, 2004
- Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells,Bone, 2003
- Plasticity of marrow-derived stem cellsBlood, 2003
- Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factorMolecular Therapy, 2003
- Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibilityBiomaterials, 2003
- Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cellsNature Biotechnology, 2002
- Cutting Edge: Telomerase Activation in Human T Lymphocytes Does Not Require Increase in Telomerase Reverse Transcriptase (hTERT) Protein But Is Associated with hTERT Phosphorylation and Nuclear TranslocationThe Journal of Immunology, 2001
- Design of synthetic polymeric structures for cell transplantation and tissue engineeringClinical Materials, 1993
- Tissue Engineering by Cell Transplantation Using Degradable Polymer SubstratesJournal of Biomechanical Engineering, 1991